Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder

被引：5
|
作者：
Olivieri, Giorgia [1 ]
Nociti, Viviana [2 ,3 ]
Iorio, Raffaele [2 ]
Stefanini, Maria Chiara [1 ]
Losavio, Francesco Antonio [2 ]
Mirabella, Massimiliano [2 ]
Mariotti, Paolo [1 ]
机构：
[1] Catholic Univ, Unit Child Neuropsychiat, Rome, Italy
[2] Catholic Univ, Inst Neurol, Dept Geriatr Neurosci & Orthoped, I-00168 Rome, Italy
[3] Don C Gnocchi Fdn Onlus, Milan, Italy
来源：
NEUROLOGICAL SCIENCES | 2015年 / 36卷 / 12期
关键词：
Pediatric NMOSD; Aquaporin-4; Rituximab; First-line therapy;
D O I：
10.1007/s10072-015-2368-x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2301 / 2302
页数：2
相关论文
共 50 条
  • [21] ORGANIZING PNEUMONIA: AN ETIOLOGICAL DILEMMA IN PATIENTS ON RITUXIMAB FOR TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER
    Freeman, Howard
    Zuckerman, Omry
    O'Sullivan, Mary
    CHEST, 2024, 166 (04) : 5626A - 5627A
  • [22] Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder
    Umeton, Raffaella Pizzolato
    Waltz, Michael
    Aaen, Gregory S.
    Benson, Leslie
    Gorman, Mark
    Goyal, Manu
    Graves, Jennifer S.
    Harris, Yolanda
    Krupp, Lauren
    Lotze, Timothy E.
    Shukla, Nikita M.
    Mar, Soe
    Ness, Jayne
    Rensel, Mary
    Schreiner, Teri
    Tillema, Jan-Mendelt
    Roalstad, Shelly
    Rodriguez, Moses
    Rose, John
    Waubant, Emmanuelle
    Weinstock-Guttman, Bianca
    Casper, Charles
    Chitnis, Tanuja
    NEUROLOGY, 2023, 100 (09) : E985 - E994
  • [23] Neuropsychological Profiles in Pediatric Neuromyelitis Optica Spectrum Disorder
    Gordon-Lipkin, Eliza
    Mealy, Maureen A.
    Ferenc, Lisa
    Ryan, Matthew
    Levy, Michael
    Arenivas, Ana
    NEUROLOGY, 2017, 88
  • [24] Neuropsychological Profiles in Pediatric Neuromyelitis Optica Spectrum Disorder
    Gordon-Lipkin, E.
    Mealy, M.
    Ferenc, L.
    Ryan, M.
    Levy, M.
    Arenivas, A.
    ANNALS OF NEUROLOGY, 2017, 82 : S277 - S277
  • [25] Inebilizumab for treatment of neuromyelitis optica spectrum disorder
    Tullman, Mark J.
    Zabeti, Aram
    Vuocolo, Scott
    Dinh, Quinn
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (05) : 341 - 352
  • [26] Satralizumab in the treatment of neuromyelitis optica spectrum disorder
    Duchow, Ankelien
    Bellmann-Strobl, Judith
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (01) : 49 - 59
  • [27] Cyclophosphamide treatment in Neuromyelitis Optica Spectrum Disorder
    Gulluoglu, H.
    Uysal, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 798 - 798
  • [28] Eculizumab in the treatment of neuromyelitis optica spectrum disorder
    Nabizadeh, Fardin
    Moghadasi, Abdorreza Naser
    CURRENT JOURNAL OF NEUROLOGY, 2023, 22 (02): : 140 - 143
  • [29] Advances in the Treatment of Neuromyelitis Optica Spectrum Disorder
    Wallach, Asya Izraelit
    Tremblay, Matthew
    Kister, Ilya
    NEUROLOGIC CLINICS, 2021, 39 (01) : 35 - 49
  • [30] Eculizumab in the treatment of neuromyelitis optica spectrum disorder
    Giglhuber, Katrin
    Berthele, Achim
    IMMUNOTHERAPY, 2020, 12 (14) : 1053 - 1066
12345